tiprankstipranks
Trending News
More News >
IntelliPharmaCeutics International (IPCIQ)
OTHER OTC:IPCIQ
US Market
Advertisement

IntelliPharmaCeutics International (IPCIQ) Price & Analysis

Compare
144 Followers

IPCIQ Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

5.56%94.44%
Insiders
5.56% Other Institutional Investors
94.44% Public Companies and
Individual Investors

IPCIQ FAQ

What was IntelliPharmaCeutics International’s price range in the past 12 months?
IntelliPharmaCeutics International lowest stock price was $0.15 and its highest was $0.15 in the past 12 months.
    What is IntelliPharmaCeutics International’s market cap?
    IntelliPharmaCeutics International’s market cap is $2.43M.
      When is IntelliPharmaCeutics International’s upcoming earnings report date?
      IntelliPharmaCeutics International’s upcoming earnings report date is Apr 21, 2025 which is 93 days ago.
        How were IntelliPharmaCeutics International’s earnings last quarter?
        Currently, no data Available
        Is IntelliPharmaCeutics International overvalued?
        According to Wall Street analysts IntelliPharmaCeutics International’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does IntelliPharmaCeutics International pay dividends?
          IntelliPharmaCeutics International does not currently pay dividends.
          What is IntelliPharmaCeutics International’s EPS estimate?
          IntelliPharmaCeutics International’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does IntelliPharmaCeutics International have?
          IntelliPharmaCeutics International has 35,002,666 shares outstanding.
            What happened to IntelliPharmaCeutics International’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of IntelliPharmaCeutics International?
            Currently, no hedge funds are holding shares in IPCIQ

            Company Description

            IntelliPharmaCeutics International

            Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of existing and new pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi in 1998 and is headquartered in Toronto, Canada.
            Similar Stocks
            Company
            Price & Change
            Follow
            RedHill Biopharma
            Palatin Technologies
            Avinger
            EyePoint Pharmaceuticals
            PTC Therapeutics
            Kala Pharmaceuticals
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis